-
AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI─enabled research
14 Jun 2025 03:37 GMT
… terms of the agreement, AstraZeneca and CSPC agree to … AstraZeneca’s presence in China following the $2.5 billion investment … products.
Under the agreement, AstraZeneca will have rights to … identified under this agreement.
AstraZeneca is a global, science- …
-
TEMPUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tempus AI, Inc. and Encourages Investors to Contact the Firm
14 Jun 2025 01:00 GMT
… inclusive (the “Class Period”). Investors have until August 11, 2025 … risked scrutiny and unsustainability; (4) AstraZeneca had reduced its financial commitments … firm represents individual and institutional investors in commercial, securities, derivative, …
-
TEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Tempus AI, Inc. Class Action
14 Jun 2025 00:31 GMT
… filed on behalf of investors who purchased or otherwise … Inc. (TEM) Misled Investors Regarding its Business Prospects According … and unsustainability; (4) AstraZeneca had reduced its financial commitments … 4) issues with the AstraZeneca and Pathos AI deal that …
-
AstraZeneca in deal with China firm worth up to £4bn
13 Jun 2025 21:36 GMT
… and sales-related milestones.
AstraZeneca has been ploughing cash into … capital Beijing.
Forward thinking: AstraZeneca has agreed a deal … not allowed.'
DIY INVESTING PLATFORMS
Affiliate links: If you … .
Compare the best investing account for you
-
AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech
13 Jun 2025 20:22 GMT
… Sharon Barr, who leads AstraZeneca’s biopharmaceuticals research and … The deal comes as AstraZeneca increases its investment in China, as … it announced a plan to invest $2.5bn in the … Like many pharmaceutical companies, AstraZeneca already uses AI for …
-
AstraZeneca inks China AI research deal for chronic diseases
13 Jun 2025 19:59 GMT
… to tackle chronic diseases.
AstraZeneca, which has a pre- … earlier this year plans to invest $2.5 billion in … billion people globally,” said AstraZeneca executive vice president Sharon Barr … platform”, the firm said.
AstraZeneca said the agreement will see …
-
AstraZeneca Inks $5.3B Deal With CSPC Pharma For Developing New Oral Drug Candidate, But Retail’s In No Mood To Cheer
13 Jun 2025 19:24 GMT
… sales of the products.
AstraZeneca, meanwhile, will have the … March, AstraZeneca announced a $2.5 billion investment in a … s presence in China, AstraZeneca said.
On Stocktwits, retail … sentiment around AstraZeneca stayed within the ‘neutral’ …
-
AstraZeneca strikes multibillion-dollar research deal with Chinese group
13 Jun 2025 18:59 GMT
… in China follows AstraZeneca’s $2.5 billion investment announcement in Beijing … Smith and Amnesty International UK
ASTRAZENECA
AstraZeneca has placed Wang on “extended … is one of AstraZeneca’s largest AI investments.
AstraZeneca will have exclusive licence …
-
Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025
13 Jun 2025 19:00 GMT
… Fraud Class Action Impacted investors may also contact attorney … relationship with long-term customer AstraZeneca as an example. Importantly, … as an advocate for investors who are victims of … to securing recoveries for investors who have incurred damages …
-
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
13 Jun 2025 19:00 GMT
… brief rundown of news involving AstraZeneca and Third Harmonic Bio, as … you may have missed.
AstraZeneca on Friday formed a new … a 2024 deal that handed AstraZeneca an oral, lipid-lowering therapy … the British drugmaker's investment in China. In March, the …